This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sucampo Pharmaceuticals Inc (SCMP)

NASDAQ: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 33.37M 13.13M 6.42M 4.84M
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -13.37M -3.68M -3.97M 1.18M
(Increase) Decrease in Inventories -1.44M 206.00K -163.00K 87.00K
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -1.72M -3.44M 2.24M -1.45M
(Decrease) Increase In Other Current Liabilities -7.00K 2.84M -4.72M 15.00K
(Increase) Decrease In Other Working Capital 1.48M 9.52M -4.89M -1.07M
Other Non-Cash Items -660.00K 9.77M -815.00K 26.88M
Net Cash From Continuing Operations 18.59M 30.88M -5.42M 12.00M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 18.59M 30.88M -5.42M 12.00M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -5.44M -66.00K -168.00K -3.44M
Acquisitions -161.19M 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -368.00K 25.83M -10.83M 26.14M
Cash Provided by Financing Activities
Net Cash From Investing Activities -131.15M 12.96M -13.88M -589.00K
Issuance of Debt 235.91M 0.00 10.60M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 5.75M 9.15M 7.64M 331.00K
Repayment of Long-Term Debt -8.24M -24.90M -7.54M -7.50M
Repurchase of Capital Stock -43.96M 0.00 -336.00K -1.28M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -40.13M 340.00K 213.00K 0.00
Net Cash From Financing Activities 149.34M -15.41M 10.58M -8.45M
Effect of Exchange Rate Changes -113.00K -904.00K 798.00K -1.60M
Net Change in Cash & Cash Equivalents 36.66M 27.52M -7.92M 1.36M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

SCMP Sucampo Pharmaceuticals Inc

Chart of SCMP

Analysts Ratings for SCMP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 4 4 3
Moderate Buy 0 0 0 0
Hold 2 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

SCMP Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs